Biostatistics

Webinar

Estimands in Oncology: Are we Censoring for the Right Reason?

July 1, 2021
Webinar

Practice-Oriented Pragmatic Trials Can Integrate Innovations More Rapidly in Evidence-Based Medicine

June 1, 2021
Webinar

SOCRATES (Standard of Care Randomized Trials) and the Need for Big Randomized Data

April 26, 2021
Article

Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer

November 25, 2020
Webinar

Clinical Trials for, and Despite, COVID-19

October 27, 2020
Webinar

Companion Diagnostics and Clinical Development in Oncology: a Statistical Perspective

September 17, 2020
Case Study

The REALI pooled analysis of the European post-marketing studies for the TOUJEO® product

August 24, 2020
Article

Evaluating the Potential of Relapse-Free Survival as a Surrogate for Overall Survival in the Adjuvant Therapy of Melanoma with Checkpoint Inhibitors

August 10, 2020
Article

Assessing Treatment Benefit in Immuno-oncology

June 9, 2020
Article

Statistical Aspects in Adjuvant and Neoadjuvant Trials for Gastrointestinal Cancer in 2020: Focus on Time-To-Event Endpoints

June 8, 2020

When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything. That’s why it’s IDDI.

Start Now